Triptolide and its prodrug minnelide target high-risk myc-amplified medulloblastoma in preclinical models

Rally Foundation career development award 20CDN46, National Institute of Neurological Disorders and Stroke (NINDS) of the NIH award K01NS119351, V Foundation Scholar award V2022-008, a Vince Lombardi Cancer Foundation grant, an American Cancer Society Institutional Research grant awarded to the Hollings Cancer Center IRG-19-137-20, Monka Foundation funds, Alex Lemonade Stand Foundation “A” award 23-28298, Tumor Biology Research Grant for Trainees from Sylvester Cancer Center, National Cancer Institute (NCI) T32 CA009686, a Southeastern Brain Tumor Foundation, NINDS R01NS110591, NINDS NS118023, NCI R00 CA241367, a Hollings Cancer Center LOWVELO postdoctoral fellowship, a Hollings Cancer Center LOWVELO graduate fellowship, SREB Doctoral Scholarship SC15321, a Medical University of South Carolina College of Graduate Studies Odyssey fellowship, NIH P30CA046934 awarded to the CU Cancer Center Bioinformatics and Biostatistics Shared Resource Core, NCI CA-096832, NCI CA-21765, and funds from the American Lebanese Syrian Associated Charities (ALSA).